1. US Food and Drug Administration. ‘Off-label’ and investigational use of marketed drugs, biologics, and medical devices. http://www.fda.gov/oc/ohrt/irbs/offlabel.html .
2. Radley DC, Finkelstein SN, Stafford RS . Off-label prescribing among office-based physicians. Arch Intern Med 2006; 166: 1021–1026.
3. Dooley AG . Off-label drug use. Med Health RI 2007; 90: 63–65.
4. Plaza CI . Health insurance oversight issue brief; mandated benefits: off-label drug coverage requirements: (year end report—2004). Issue Brief Health Policy Track Serv 2004; 1–9.
5. Henry V . Off-label prescribing: legal implications. J Leg Med 1999; 20: 365–384.